The association between peptidoglycan recognition protein-1 and coronary and peripheral atherosclerosis: Observations from the Dallas Heart Study

Donald W. Reynolds Cardiovascular Clinical Research Center, University of Texas Southwestern Medical Center, Dallas, 75390-9047, United States.
Atherosclerosis (Impact Factor: 3.99). 08/2008; 203(2):569-75. DOI: 10.1016/j.atherosclerosis.2008.07.015
Source: PubMed


Peptidoglycan recognition protein-1 (PGLYRP-1) is part of the innate immune system and binds to peptidoglycan, a component of bacterial cell walls that has been found in human atherosclerotic lesions. Chronic exposure to bacterial antigens may cause or exacerbate the inflammatory response to lipid deposition within arterial walls. We hypothesized that PGLYRP-1 is associated with subclinical atherosclerosis as measured by computed tomography and magnetic resonance imaging.
PGLYRP-1 was measured in 3222 subjects in the Dallas Heart Study, a probability-based population sample age 30-65 including 50% African-Americans and 56% women. Coronary artery calcium (CAC) was measured by electron beam computed tomography (n=2467), abdominal aortic wall thickness (AWT) by magnetic resonance imaging (MRI) (n=2270), and abdominal aortic plaque burden (APB) by MRI (n=2256). In univariable analyses, increasing levels of PGLYRP-1 were associated with all major cardiovascular risk factors, with inflammatory markers such as C-reactive protein, and with CAC, AWT, and APB (p<0.0001 for each). In multivariable models adjusted for traditional risk factors, logPGLYRP-1 remained significantly associated with CAC (OR 1.1, 95% CI 1.01-1.3 per S.D.; p=0.04) and AWT (p=0.009) but not APB (p=0.09). Further adjustment for novel biomarkers associated with PGLYRP-1 and atherosclerosis attenuated the association with CAC (p=0.18) but not with AWT (p=0.01) or APB (p=0.037).
In this first reported clinical study of PGLYRP-1 in humans, PGLYRP-1 levels were independently associated with atherosclerosis phenotypes that represent different vascular beds and stages of atherosclerosis.

Download full-text


Available from: Anand Rohatgi, Mar 17, 2015
10 Reads
  • Source
    • "Chitinous copepods appear well suited to harbour vibrios and thus serve as an important means of facilitating Vibrio growth (Romalde et al., 1990), distribution and spread (Maugeri et al., 2004; Lindsey et al., 2009; Turner et al., 2009). Moreover, the interface between copepod life cycles and marine deep-water environments has been noted (Rohatgi et al., 2009). This life cycle promotes close proximity between copepods to marine benthic environments, such as provided by sponges, that would be necessary to establish an association with ''deep-water'' vibrios. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Vibrio represents a diverse bacterial genus found in different niches of the marine environment, including numerous genera of marine sponges (phylum Porifera), inhabiting different depths and regions of benthic seas, that are potentially important in driving adaptive change among Vibrio spp. Using 16S rRNA gene sequencing, a previous study showed that sponge‐derived (SD) vibrios clustered with their mainstream counterparts present in shallow, coastal ecosystems, suggesting a genetic relatedness between these populations. Sequences from the topA, ftsZ, mreB, rpoD, rctB and toxR genes were used to investigate the degree of relatedness existing between these two separate populations by examining their phylogenetic and genetic disparity. Phylogenies were constructed from the concatenated sequences of the six housekeeping genes using maximum‐parsimony, maximum‐likelihood and neighbour‐joining algorithms. Genetic recombination was evaluated using the incongruence length difference test, Split decomposition and measuring overall compatibility of sites. This combined technical approach provided evidence that SD Vibrio strains are largely genetically homologous to their shallow‐water counterparts. Moreover, the analyses conducted support the existence of extensive horizontal gene transfer between these two groups, supporting the idea of a single panmictic population structure among vibrios from two seemingly distinct, marine environments.
    Cladistics 02/2013; 29(1). DOI:10.1111/j.1096-0031.2012.00416.x · 6.22 Impact Factor
  • Source
    • "For example, matrix metalloproteinases (for example, MMP2) are thought to participate in atherogenic inflammation [38]. The role of innate immunity in atherogenesis is less well established; PGLYRP1 participates in recognition of bacteria by neutrophils, but is independently associated with coronary artery calcification and abdominal aortic plaque [39]. The difference in PGLYRP1 concentration among women taking E+P versus E-alone suggests a possible mechanistic link. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Women's Health Initiative randomized trials of postmenopausal hormone therapy reported intervention effects on several clinical outcomes, with some important differences between estrogen alone and estrogen plus progestin. The biologic mechanisms underlying these effects, and these differences, have yet to be fully elucidated. Baseline serum samples were compared with samples drawn 1 year later for 50 women assigned to active hormone therapy in both the estrogen-plus-progestin and estrogen-alone randomized trials, by applying an in-depth proteomic discovery platform to serum pools from 10 women per pool. In total, 378 proteins were quantified in two or more of the 10 pooled serum comparisons, by using strict identification criteria. Of these, 169 (44.7%) showed evidence (nominal P < 0.05) of change in concentration between baseline and 1 year for one or both of estrogen-plus-progestin and estrogen-alone groups. Quantitative changes were highly correlated between the two hormone-therapy preparations. A total of 98 proteins had false discovery rates < 0.05 for change with estrogen plus progestin, compared with 94 for estrogen alone. Of these, 84 had false discovery rates <0.05 for both preparations. The observed changes included multiple proteins relevant to coagulation, inflammation, immune response, metabolism, cell adhesion, growth factors, and osteogenesis. Evidence of differential changes also was noted between the hormone preparations, with the strongest evidence in growth factor and inflammation pathways. Serum proteomic analyses yielded a large number of proteins similarly affected by estrogen plus progestin and by estrogen alone and identified some proteins and pathways that appear to be differentially affected between the two hormone preparations; this may explain their distinct clinical effects.
    Genome Medicine 12/2009; 1(12):121. DOI:10.1186/gm121 · 5.34 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The most important application of the dual-modality PET/CT is the ability to efficiently display the fused data. However, in PET/CT fusion, the amount of information displayed is often impaired as the CT data occupies greater range of contrast than that is possible to display without enhancements. A common approach to improving the CT information in the PET/CT fusion is by enhancing the contrast range of the CT data which can improve on the accuracy of structure localization and PET/CT interpretation. In this study, we present an interactive multi-image fusion which optimizes the display of the information from dual-modality PET/CT data. By interactively selecting a specific CT contrast range and assigning the resultant image as a layer, the multi-layers can be constructed and then fused using the multi-image pixel compositing. The enhanced CT data is further fused with the PET data for PET/CT diagnosis. The proposed algorithm is able to simultaneously display greater amount of information from the fused PET/CT data and reveal substantial details of the CT data that would not have been possible with standard PET/CT fusion. The preliminary results are encouraging and show potential in the PET/CT diagnosis and interpretation
    Nuclear Science Symposium Conference Record, 2005 IEEE; 11/2005
Show more